Intrahepatic
islet transplantation is an
experimental therapy for
type 1 diabetes. In the present studies, we sought to address the following questions: 1) In humans, do intrahepatic transplanted islets reestablish coordinated puslatile insulin secretion? and 2) To what extent is
insulin secreted by intrahepatic transplanted islets delivered to the hepatic sinusoids (therefore effectively restoring a portal mode of
insulin delivery) versus delivered to the hepatic central vein (therefore effectively providing a systemic form of
insulin delivery)? To address the first question, we examined
insulin concentration profiles in the overnight fasting state and during a hyperglycemic clamp ( approximately 150 mg/dl) in 10 recipients of islet transplants and 10 control subjects. To address the second question, we measured first-pass hepatic
insulin clearance in two recipients of islet autografts after
pancreatectomy for
pancreatitis versus five control subjects by direct catheterization of the hepatic vein. We report that coordinate pulsatile insulin secretion is reestablished in islet transplant recipients and that
glucose-mediated stimulation of insulin secretion is accomplished by amplification of
insulin pulse mass. Direct hepatic catheterization studies revealed that intrahepatic islets in humans do deliver
insulin directly to the hepatic sinusoid because approximately 80% of the
insulin is extracted during first pass. In conclusion, intrahepatic
islet transplantation effectively restores the liver to pulsatile
insulin delivery.